Metabolic Modulation in Cancer Cell Dynamics

Cancer cells exhibit profound metabolic reprogramming to support rapid proliferation, survival under stress and dissemination. Beyond the classical preference for glycolysis even in the presence of oxygen, known as the Warburg effect, tumour cells demonstrate remarkable metabolic plasticity, dynamically shifting between glycolysis and mitochondrial oxidative phosphorylation in response to nutrient availability and microenvironmental cues. Amino acid and lipid pathways are co-opted to supply biosynthetic precursors, while oncometabolites influence epigenetic regulators and signalling networks. Hypoxic regions within solid tumours stabilise hypoxia-inducible factors, driving adaptive changes in carbohydrate, glutamine and lipid metabolism. Emerging research has harnessed advanced metabolomic profiling and live-cell sensors to delineate these pathways, revealing vulnerabilities exploitable by targeted therapies. A detailed understanding of metabolic modulation in cancer not only illuminates tumour biology but also guides the development of precision-based diagnostics and interventions with broad clinical relevance.

Research from Nature Portfolio

Recent studies have demonstrated that when glycolysis is pharmacologically suppressed in diverse tumour cell lines, cells compensate by upregulating mitochondrial oxidative phosphorylation through autophagy-dependent enhancement of mitochondrial function. This shift relies heavily on glutamine and glutamate influx into the tricarboxylic acid cycle, sustaining ATP production and survival. In parallel, the development of a genetically encoded FRET-based sensor for l-2-hydroxyglutarate has enabled real-time monitoring of this oncometabolite in living cells. By identifying a specific transcriptional regulator that responds to l-2-hydroxyglutarate, researchers have mapped dynamic accumulation under hypoxia and nutrient stress, thus illuminating a direct link between oncometabolite levels and hypoxia-driven signalling pathways.

Metabolic Modulation in Cancer Cell Dynamics publication trend

The graph below shows the total number of articles in metabolic modulation in cancer cell dynamics across all publications each year (not limited to Nature Index journals).

Technical terms

Glycolysis: Series of enzymatic reactions converting glucose to pyruvate with production of ATP and NADH.

Oxidative phosphorylation: Mitochondrial process coupling electron transport to ATP synthesis.

Oncometabolite: Metabolite whose accumulation drives oncogenic processes and alters gene regulation.

Hypoxia-inducible factor: Transcription factor stabilised under low oxygen that regulates genes for metabolic adaptation and survival.

Reductive carboxylation: Reverse reaction of isocitrate dehydrogenase converting α-ketoglutarate to citrate under mitochondrial impairment.

Tricarboxylic acid cycle: Series of mitochondrial reactions oxidising acetyl-CoA to generate energy carriers and biosynthetic precursors.

α-Ketoglutarate: Key tricarboxylic acid cycle intermediate linking carbon metabolism to amino acid synthesis and epigenetic regulation.

References

1. Glycolytic suppression dramatically changes the intracellular metabolic profile of multiple cancer cell lines in a mitochondrial metabolism-dependent manner. Scientific Reports (2019).
2. An l-2-hydroxyglutarate biosensor based on specific transcriptional regulator LhgR. Nature Communications (2021).
3. Acidic pH Is a Metabolic Switch for 2-Hydroxyglutarate Generation and Signaling*. Journal of Biological Chemistry (2016).
4. HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells. Cells (2021).
5. Reductive TCA cycle catalyzed by wild-type IDH2 promotes acute myeloid leukemia and is a metabolic vulnerability for potential targeted therapy. Journal of Hematology & Oncology (2022).